Hero Image

Sparing Patients Unnecessary Chemo: Globally Validated AI Diagnostics at a Fraction of the Cost

An AI-driven breast cancer test analyzes five tumour biomarkers alongside clinical data to generate a recurrence-risk score, helping identify who needs chemotherapy and who can safely avoid it. Globally patented and validated, it makes precision oncology far more affordable.

Share

LinkedIn Icon Facebook Icon Twitter Icon
sector

Sector

Healthcare
education

Solution

Cancer Care
Healthcare

Technology

AI
space

State of Origin

Karnataka

Disclaimer:

  • Features ‘as is’ submissions and neither constitutes endorsement, certification, recommendation, or validation by NITI Aayog nor makes NITI Aayog liable in any manner.

Resources to Replicate This Idea

BUILD YOUR OWN INTERVENTION


    Funding/cost details: How much funding did the innovator deploy? How did they go from pilot to scaling? What schemes supported the funding?Tech partners: How did the innovators choose their tech partners?Contact information: For other queries

    Handpicked stories tailored just for you

    Explore stories that inspire, inform, and ignite new ideas across tech, innovation, and real-world impact

    dotted-line

    Solar-Charged, AI-Optimised Boats Cut Fuel Costs by 95% and Make Water Cleanup Safer

    No Space for Trees? Sun-Driven Microalgae Tech Scrubs City Air

    One Phone Call, Personalized Crop Advice: Voice AI for India’s Farmers

    Solving India’s 1.5 Lakh Tonne Waste Problem, One Home at a Time

    No Spray, No Residue: The Pheromone Tech Protecting 100,000+ Acres of Indian Farmland

    India’s Community-Verified Digital Locator for HIV Prevention Services

    View All Videos